Rookie FDA Mistake By Australian Cannabis Company Investigating BO Puts Investors All In A Sweat

It’s certainly stupid season when it comes to cannabis in Australia at the moment.   Motley Fool reports The Botanix Pharmaceuticals Ltd (ASX: BOT) share price has returned from its trading halt and crashed deep into the red. In morning trade, the cannabis-focused ASX dermatology share is down a massive 36% to 11.5 cents. What’s going on with […]

Go to Source

Powered by WPeMatico